Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Clinical Study of LV009 Injection for the Treatment of Hematologic and Lymphoid Malignancies [Phase 1]
Phase 1 clinical trial update for LV009 injection in hematologic and lymphoid cancers, including Non-Hodgkin Lymphoma and Acute Lymphoblasti…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Amping up With PemJAK [Phase 2]
A Phase 2 clinical trial of PemJAK for multiple lymphoma subtypes is currently recruiting, including non-Hodgkin lymphoma and Hodgkin lympho…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Mosunetuzumab for CLL MRD Clearance [Phase 1, Phase 2]
Clinical trial update for mosunetuzumab in chronic lymphocytic leukemia focusing on measurable residual disease clearance in Phase 1/2 studi…
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma [Phase 1]
A Phase 1 trial evaluating EBV-specific cytotoxic T lymphocytes for Epstein-Barr virus–associated lymphomas, currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma [Phase 1]
An ongoing Phase 1 clinical trial update for AS-1763 in adults with previously treated B-cell malignancies, including chronic lymphocytic le…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Study of CART Cell (MB-CART19.1) in Patients With Relapsed or Refractory CD19 Positive NHL [Phase 2]
Phase 2 trial evaluating MB-CART19.1, a CD19-directed CAR-T cell therapy, in relapsed or refractory CD19-positive non-Hodgkin lymphoma; curr…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: SARcopenia and Simplified Geriatric Assessment in Lymphoma Patients Undergoing CAR-T Cell Therapy: the FIL_SAR-CAR Project
A clinical trial update on the FIL_SAR-CAR project evaluating sarcopenia and simplified geriatric assessment in Non-Hodgkin lymphoma patient…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Muscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell Transplant
An ongoing clinical trial investigating muscle dysfunction in patients with hematologic diseases referred for stem cell transplantation.
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: RADVAX™ for Relapsed/Refractory Non-Hodgkin Lymphoma: A Phase II Trial of Pembrolizumab + Low Dose Radiotherapy [Phase 2]
Phase II trial evaluating pembrolizumab plus low-dose radiotherapy for relapsed/refractory non-Hodgkin lymphoma; the study is listed as acti…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial
A prospective registry study collecting diagnosis, treatment, and outcome data for adults with acute lymphoblastic leukemia and related dise…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Duvelisib in Combination With BMS-986345 in Lymphoid Malignancy [Phase 1]
A Phase 1 trial evaluating the combination of duvelisib with BMS-986345 in lymphoid malignancies, including non-Hodgkin lymphoma and Hodgkin…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma [Phase 3]
A Phase 3 study comparing EAP versus disease-specific chemotherapy regimens for hematopoietic stem cell mobilization in patients with Non-Ho…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: A Phase I Study of Bendamustine and Melphalan Conditioning and Autologous Stem Cell Transplantation for Treatment of Multiple Myeloma and Relapsed/Refractory B-cell Lymphoma in Elderly Patients [Phase 1]
This is a Phase I study evaluating conditioning with bendamustine and melphalan followed by autologous stem cell transplantation for elderly…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
This ClinicalTrials.gov entry describes a recruiting USC-led study evaluating social health, activity behaviors, and quality of life among y…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Mozobil for Autologous Hematopoietic Stem Cell Transplantation [Phase 2]
Phase 2 clinical trial update for Mozobil (plerixafor) in autologous hematopoietic stem cell transplantation, enrolling patients with multip…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Study Evaluating SC262 in Subjects With r/r Non-Hodgkin's Lymphoma (VIVID) [Phase 1]
A Phase 1 clinical trial evaluating SC262 in patients with relapsed/refractory Non-Hodgkin's lymphoma, including Large B-cell lymphoma; curr…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Pevonedistat and Ibrutinib in Treating Participants With Relapsed or Refractory CLL or Non-Hodgkin Lymphoma [Phase 1]
This clinical trial update describes a Phase 1 study of pevonedistat in combination with ibrutinib for relapsed or refractory chronic lympho…
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: Lenalidomide and Blinatumomab for the Treatment of Relapsed Non-Hodgkin Lymphoma [Phase 1]
This Phase 1 trial examined lenalidomide combined with blinatumomab for relapsed non-Hodgkin lymphoma across multiple subtypes and has compl…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: The Safety and Efficacy of BRL-201 in the Treatment of r/r B Lymphocyte Non-Hodgkin Lymphoma [Phase 1]
This Phase 1 trial examines the safety and preliminary efficacy of BRL-201 in relapsed/refractory B-cell non-Hodgkin lymphoma and is current…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Universal CAR-T Cell Therapy for NHL [NA]
Recruitment is ongoing for a universal CAR-T cell therapy being studied in non-Hodgkin lymphoma (B-cell subtype), sponsored by Bioray Labora…
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: Activated T Lymphocytes Expressing CARs, Relapsed CD19+ Malignancies Post-Allo HSCT(CARPASCIO) [Phase 1]
Phase 1 trial update of CAR T cells (CARPASCIO) targeting CD19 in relapsed CD19+ malignancies after allogeneic HSCT. The study is currently …
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: Emapalumab Prevention of CAR-T Cell Associated Toxicities [Phase 2]
A Phase 2 clinical trial update evaluating emapalumab for preventing CAR-T cell–related toxicities in patients with relapsed or refractory B…
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating CTX112 in relapsed or refractory B-cell malignancies is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer [Phase 1]
A Phase 1 trial evaluating natural killer cell therapy in combination with Interleukin-2 and the TGF-beta receptor I inhibitor vactosertib f…
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine [Phase 1]
A Phase 1 clinical trial evaluating a haploidentical bone marrow transplant using post-transplant cyclophosphamide and bendamustine has comp…